GOLDMAN SACHS GROUP INC - CULLINAN ONCOLOGY INC ownership

CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 2.12 and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CULLINAN ONCOLOGY INC
ValueSharesWeighting
Q3 2023$779,305
-28.6%
86,111
-15.1%
0.00%
Q2 2023$1,091,355
-40.7%
101,427
-43.6%
0.00%
Q1 2023$1,839,558
+3.9%
179,820
+7.1%
0.00%
Q4 2022$1,771,240
-57.7%
167,890
-48.6%
0.00%
-100.0%
Q3 2022$4,189,000
+97.7%
326,750
+97.7%
0.00%
Q2 2022$2,119,000
+141.9%
165,309
+97.6%
0.00%
Q1 2022$876,000
-29.4%
83,651
+4.0%
0.00%
Q4 2021$1,240,000
-65.1%
80,401
-49.0%
0.00%
-100.0%
Q3 2021$3,555,000
+1017.9%
157,501
+1175.0%
0.00%
Q2 2021$318,000
-86.4%
12,353
-78.0%
0.00%
-100.0%
Q1 2021$2,336,00056,0600.00%
Other shareholders
CULLINAN ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM BioImpact LLC 7,648,268$69,216,82518.48%
CHI Advisors LLC 3,414,189$30,898,41012.25%
Nextech Invest Ltd. 1,221,145$11,051,3623.35%
TANG CAPITAL MANAGEMENT LLC 621,138$5,621,2990.79%
BVF INC/IL 3,196,701$28,930,1440.78%
Parkman Healthcare Partners LLC 438,745$3,970,6420.73%
Velan Capital Investment Management LP 75,000$678,7500.55%
BRAIDWELL LP 1,908,865$17,275,2280.55%
Boxer Capital, LLC 1,074,082$9,720,4420.52%
DAFNA Capital Management LLC 127,284$1,151,9200.36%
View complete list of CULLINAN ONCOLOGY INC shareholders